Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: MannKind Corporation, 3 years.
MannKind Corporation
Director
BeOne Medicines Ltd.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
BeOne Medicines Ltd. June 11, 202697.1%
-
MannKind Corporation May 20, 202692.1%
-
MannKind Corporation May 14, 202595.3%
-
MannKind Corporation May 15, 202495.7%
-
MannKind Corporation May 25, 202395.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 11, 2026 | BeOne Medicines Ltd. | Grant or award | +18,980 | — | — |
| Mar 1, 2026 | MannKind Corporation | Grant or award | +35,000 | $3.27 | $114,450 |
| May 21, 2025 | BeOne Medicines Ltd. | Grant or award | +10,985 | — | — |
| May 14, 2025 | MannKind Corporation | Grant or award | +25,000 | $4.56 | $114,000 |
| Jun 5, 2024 | BeOne Medicines Ltd. | Grant or award | +16,341 | — | — |
| Feb 4, 2024 | MannKind Corporation | Grant or award | +40,000 | $3.27 | $130,800 |
| Jun 15, 2023 | BeOne Medicines Ltd. | Grant or award | +12,922 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.